Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

AdvaMed CEO Says Some Top Agenda Items For the Year Are ‘Taking A Back Seat’ To Address COVID-19

Apr 17 2020

comments made by Scott Whitaker (left) and Kevin Lobo (right) — ADVAMED CEO SCOTT WHITAKER (LEFT) AND CHAIRMAN KEVIN LOBO AT A September 2019 PRESS CONFERENCE • Source: Ferdous Al-Faruque

Related Content

Industry Advocacy Group Goes Global After Device Tax Repeal

Jan 27 2020

COVID-19: String Of FDA Guidance Docs Lay Bare Enforcement Policies For Infusion Pumps, ECMO Devices, Thermometers, And More

Apr 07 2020

Industry Asks If Small Business Loan Relief Applies To Companies With Equity Investors

Apr 01 2020

‘Have Some Level Of Fear’: How Scrapped FDA Inspections, Hastily Made Ventilators Could Portend Product Problems

Apr 01 2020

It’s Raining EUAs: US FDA Drops Slew Of EUAs In Response To COVID-19

Apr 13 2020

MDUFA Meeting Postponed Again Due To COVID-19, This Time Indefinitely

Apr 16 2020

Listen To Our Podcast Interview With AdvaMed’s Scott Whitaker

Apr 17 2020

Additional Topics

United States Regulation Policy Approvals Business Strategies Coronavirus COVID-19 FDA Government Payers Guidance Documents Innovation Legislation Lobbying Legal Issues Manufacturing Politics Reimbursement Review Pathway Risk Management Safety Strategy User Fees Infectious Diseases Medical Device

More from Regulation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window